Pfizer and Clear Creek Bio partner to develop oral COVID-19 drug

Pfizer partners with Clear Creek Bio to develop oral COVID-19 drug Pfizer Inc and Clear Creek Bio Inc on Tuesday announced a collaboration to identify a potential drug candidate and develop a new class of oral treatment against COVID-19, as Pfizer seeks to expand its anti-infective pipeline. Reuters Reuters

...

Pfizer already has a COVID antiviral pill Paxlovid, which the drugmaker expects to generate about $22 billion in revenue this year.

...